Omnicell Inc (STU:OC9)
€ 30.6 -1.4 (-4.38%) Market Cap: 1.40 Bil Enterprise Value: 1.31 Bil PE Ratio: 42.11 PB Ratio: 1.25 GF Score: 75/100

Q3 2025 Omnicell Inc Earnings Call Transcript

Oct 30, 2025 / 12:30 PM GMT
Release Date Price: €25.4 (-0.78%)

Key Points

Positve
  • Omnicell Inc (OMCL) reported strong financial performance with total revenues, non-GAAP EBITDA, and non-GAAP EPS exceeding the upper end of their guidance.
  • The company saw robust demand for its flagship point of care connected devices, driving top-line performance.
  • Omnicell Inc (OMCL) is progressing well in its transformation into an intelligent medication management technology company, with positive customer feedback on its Omnisphere cloud-based platform.
  • The company completed a $75 million stock repurchase program, indicating strong cash flow and shareholder value return.
  • Omnicell Inc (OMCL) is experiencing strong market validation of its products and services, with significant customer wins and increased platform adoption.
Negative
  • GAAP earnings per share decreased to $0.12 from $0.19 in the same quarter last year.
  • Non-GAAP gross margin slightly decreased to 44.2% from 44.5% in the previous year.
  • The company faced a $6 million impact on profitability due to tariffs, with expectations of similar impacts in the next quarter.
  • There are headwinds in the retail pharmacy space affecting the Enlivened health business, leading to slower than expected SA and expert services revenue growth.
  • Omnicell Inc (OMCL) is still in limited release for its compounding robot, indicating potential delays in full market deployment.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

OMCL.OQ - Omnicell Inc
Q3 2025 Omnicell Inc Earnings Call
Oct 30, 2025 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for standing by. At this time, I would like to welcome everyone to today's Omniel 3rd quarter 2025 financial results call.

All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you'd like to ask a question during this time, simply press star, followed by the number one on your telephone keypad. Once again, one. And if you'd like to withdraw your question, simply press one again.

Thank you.

I would now like to turn the call over to Kathleen Nieman, senior Vice President, Investor Relations. Kathleen.

--------------------------------------------------------------------------------
Unidentified_2 [2]
------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot